Display options
Share it on

Ann Indian Acad Neurol. 2014 Oct;17(4):398-404. doi: 10.4103/0972-2327.144008.

Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress.

Annals of Indian Academy of Neurology

Bindu Menon, Krishnan Ramalingam, Rajendiran Vinoth Kumar

Affiliations

  1. Department of Neurology, Narayana Medical College and Superspeciality Hospital, Chintareddypalem, Nellore, Andhra Pradesh, India.
  2. Department of Biochemistry, Narayana Medical College and Superspeciality Hospital, Chintareddypalem, Nellore, Andhra Pradesh, India.

PMID: 25506160 PMCID: PMC4251012 DOI: 10.4103/0972-2327.144008

Abstract

BACKGROUND: Oxidative stress has been implicated in various disorders including epilepsy. We studied the antioxidant status in patients with epilepsy and aimed at determining whether there was any difference in the antioxidant levels between patients and controls, patients who are not on antiepileptic drugs (AEDs), and on treatment, between individual AEDs and patients on monotherapy and polytherapy.

MATERIALS AND METHODS: Antioxidant levels like catalase, glutathione peroxidase (GPx), vitamin E, glutathione (GSH), thiol group (SH), uric acid, and total antioxidant capacity (TAC) were compared between 100 patients with epilepsy and equal number of controls. Twenty-five patients who were not on AEDs were compared with patients on AEDs and the control group. Patients were divided into monotherapy and polytherapy group and antioxidant status was compared between the two groups and between individual drugs.

RESULTS: Catalase, SH, vitamin E, and TAC were significantly low in patients with epilepsy than those in the control group (P < 0.001). GSH and uric acid did not show any difference; GPx in patients was significantly higher than those in the control group There were no differences in the antioxidant levels between the treated and the untreated groups; however, it was lower in untreated patients than controls (P < 0.001), suggesting that AEDs do not modify the oxidative stress. Patients on Valproate (VPA) showed higher catalase and GPx levels. Catalase was higher in the monotherapy than polytherapy group (P < 0.04).

CONCLUSION: Our study found significantly low levels of antioxidant in patients as compared to controls. AED did not influence the antioxidant status suggesting that seizures induce oxidative stress.

Keywords: Antiepileptic drugs; catalase; epilepsy; glutathione; glutathione peroxidase; seizures; thiol goup; total antioxidant capacity; uric acid; vitamin E

References

  1. Epilepsy Behav. 2011 Dec;22(4):678-84 - PubMed
  2. Free Radic Biol Med. 1993 Jun;14(6):615-31 - PubMed
  3. J Lab Clin Med. 1963 May;61:882-8 - PubMed
  4. Pediatr Pharmacol (New York). 1980;1(2):129-34 - PubMed
  5. Farmaco. 1995 Nov;50(11):811-3 - PubMed
  6. Acta Med Okayama. 2004 Jun;58(3):111-8 - PubMed
  7. Brain Res. 2012 Apr 27;1451:19-26 - PubMed
  8. Brain. 2008 Aug;131(Pt 8):2061-70 - PubMed
  9. Yonsei Med J. 1993 Mar;34(1):1-10 - PubMed
  10. Life Sci. 2006 Mar 13;78(16):1884-91 - PubMed
  11. Clin Exp Nephrol. 2005 Sep;9(3):195-205 - PubMed
  12. Neurochem Res. 2004 Sep;29(9):1749-53 - PubMed
  13. Epilepsia. 2007 Jul;48(7):1388-95 - PubMed
  14. Am J Med Genet. 1995 Jun 5;57(2):225-8 - PubMed
  15. Brain Res Bull. 2007 Jan 9;71(4):372-5 - PubMed
  16. Science. 1973 Feb 9;179(4073):588-90 - PubMed
  17. Epilepsy Res. 2004 Nov;62(1):65-74 - PubMed
  18. Curr Top Med Chem. 2012;12(9):994-1007 - PubMed
  19. Epilepsia. 2009 May;50 Suppl 5:11-4 - PubMed
  20. Biol Trace Elem Res. 2013 May;152(2):180-6 - PubMed
  21. Curr Pharm Des. 2005;11(32):4145-51 - PubMed
  22. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):608-19 - PubMed
  23. Neurosci Lett. 2007 Jun 8;420(1):76-9 - PubMed
  24. Methods Enzymol. 1984;105:121-6 - PubMed
  25. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5144-7 - PubMed
  26. Epilepsia. 2001 Jun;42(6):796-803 - PubMed
  27. Clin Chem. 1978 Apr;24(4):585-90 - PubMed
  28. Epilepsy Res. 2001 Aug;46(2):121-8 - PubMed
  29. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):698-702 - PubMed
  30. Pol J Pharmacol. 2002 Sep-Oct;54(5):521-4 - PubMed
  31. Acta Physiol Scand Suppl. 1980;492:153-68 - PubMed
  32. Analyst. 1972 Feb;97(151):142-5 - PubMed
  33. Life Sci. 1997;61(4):437-43 - PubMed
  34. Epilepsy Res. 2008 Feb;78(2-3):171-7 - PubMed
  35. Toxicology. 2006 Jan 16;217(2-3):228-32 - PubMed
  36. J Basic Clin Physiol Pharmacol. 2000;11(1):73-81 - PubMed
  37. Brain Res. 1999 Nov 20;847(2):347-51 - PubMed
  38. Epilepsy Behav. 2009 Jan;14 Suppl 1:16-25 - PubMed
  39. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1162-7 - PubMed
  40. Arch Biochem Biophys. 1959 May;82(1):70-7 - PubMed
  41. Epilepsy Res. 2002 Jan;48(1-2):71-5 - PubMed
  42. Epilepsy Res. 2007 May;74(2-3):183-92 - PubMed
  43. Clin Chim Acta. 2001 Jan;303(1-2):19-24 - PubMed
  44. Lancet Neurol. 2002 Jul;1(3):173-81 - PubMed
  45. Epilepsia. 2005;46 Suppl 7:45-51 - PubMed
  46. Science. 1959 Nov 13;130(3385):1319-23 - PubMed
  47. Eur Neurol. 2007;57(2):65-9 - PubMed
  48. Neurochem Int. 2003 Jan;42(2):173-8 - PubMed
  49. Int J Biomed Sci. 2008 Jun;4(2):89-96 - PubMed
  50. Anal Biochem. 1996 Jul 15;239(1):70-6 - PubMed
  51. J Pharmacol Sci. 2004 Dec;96(4):465-73 - PubMed
  52. Neurochem Res. 2013 Apr;38(4):780-8 - PubMed
  53. Eur J Pharmacol. 2011 Oct 1;668(1-2):65-71 - PubMed
  54. Am J Clin Nutr. 1979 Nov;32(11):2269-71 - PubMed
  55. J Physiol Biochem. 2001 Mar;57(1):43-56 - PubMed
  56. Epilepsia. 2009 Jun;50(6):1579-86 - PubMed
  57. Free Radic Biol Med. 2007 Jul 1;43(1):4-15 - PubMed
  58. Seizure. 2012 Dec;21(10):780-4 - PubMed

Publication Types